Control mechanism of JAK/STAT signal transduction pathway

Suppressor of cytokine signaling‐1 (SOCS1) was identified as the negative regulator of Janus kinase (JAK) and signal transducer and activator of transcription (STAT) signal transduction pathway. However, the kinetics and control mechanism of the pathway have not yet been fully understood. We have developed the computer simulation of the JAK/STAT pathway. Without nuclear phosphatase, SOCS1's binding to JAK did not cause the decrease in nuclear phosphorylated STAT1. However, without SH2 domain‐containing tyrosine phosphatase 2 (SHP‐2) or cytoplasmic phosphatase, it did. So nuclear phosphatase is considered to be the most important in this system. By changing parameters of the model, dynamical characteristics and control mechanism were investigated.

[1]  A. Yoshimura,et al.  The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop , 1999, The EMBO journal.

[2]  A Sasaki,et al.  Negative regulation of cytokine signaling pathways. , 2000, Annual review of immunology.

[3]  J. ten Hoeve,et al.  Identification of a Nuclear Stat1 Protein Tyrosine Phosphatase , 2002, Molecular and Cellular Biology.

[4]  W. Leonard,et al.  The Jak-STAT pathway. , 2000, Molecular immunology.

[5]  Masato Kubo,et al.  A Mutant Form of JAB/SOCS1 Augments the Cytokine-induced JAK/STAT Pathway by Accelerating Degradation of Wild-type JAB/CIS Family Proteins through the SOCS-box* , 2001, The Journal of Biological Chemistry.

[6]  K. Shuai.  The STAT family of proteins in cytokine signaling. , 1999, Progress in biophysics and molecular biology.

[7]  Paul J Hertzog,et al.  SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.

[8]  J. Darnell,et al.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors , 1995, Science.

[9]  R. Cooney,et al.  Suppressors of Cytokine Signaling (SOCS): Inhibitors of the JAK/STAT Pathway , 2002, Shock.

[10]  J. G. Zhang,et al.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Feng,et al.  Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway , 1999, Molecular and Cellular Biology.

[12]  Warren S. Alexander,et al.  Suppressor of Cytokine Signaling-1 Attenuates the Duration of Interferon γ Signal Transduction in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[13]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[14]  S. Minoguchi,et al.  The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2* , 2001, The Journal of Biological Chemistry.

[15]  C. Heldin,et al.  Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads , 2001, The EMBO journal.

[16]  Kevin M. McBride,et al.  Nuclear export signal located within the DNA‐binding domain of the STAT1transcription factor , 2000, The EMBO journal.

[17]  D. Fell,et al.  Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells , 2000, FEBS letters.

[18]  K. Shuai,et al.  Modulation of STAT signaling by STAT-interacting proteins , 2000, Oncogene.

[19]  Reinhart Heinrich,et al.  Mathematical models of protein kinase signal transduction. , 2002, Molecular cell.

[20]  S. Melmed,et al.  Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. , 1999, The Journal of clinical investigation.

[21]  H. Hauser,et al.  Dynamic redistribution of STAT1 protein in IFN signaling visualized by GFP fusion proteins. , 1999, European journal of biochemistry.

[22]  J. Darnell,et al.  Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions , 1994, Cell.